Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.90

-4.5%

Dec 1 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1350)	8/2/2005 9:01:27 AM
From: Jibacoa	Read Replies (1) of 3722

MYOG is up 45% in premarket in spite of its wider loss for the second Q,a drop of 9% in revenues and "planned sales" by insiders, albeit some bought in July at less than $8/shr.<g> But it received an "upgrade" from First Albany from "buy" to "strong buy" and the company is optimistic of the results of the ongoing PIIIs <g> At any rate,the stock traded above the $16 level and should have a good upgap.<g> bigcharts.marketwatch.com It has closed its April 2004 downgap. bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next